Avalo Therapeutics Earnings
NASDAQ: AVTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
13.65+0.22 (+1.64%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Thu, Nov 5, 2026
Fiscal period
Sep/2026
EPS estimate
$-0.63
Avalo Therapeutics earnings summary
Avalo Therapeutics is scheduled to report Sep/2026 earnings on Nov 5, 2026, with analysts expecting EPS of $-0.63.
Summary generated from market data by MetaCap's automated system. Methodology